Search results
Jennifer Lopez cancels This Is Me…Now The Tour, including Acrisure Arena stop
The Desert Sun· 4 days agoSinger Jennifer Lopez announced Friday that she is canceling her upcoming tour, This Is Me…Now The...
One of AbbVie's post-Humira hopefuls gets closer to clearing hurdle in Europe
Crain s Chicago Business· 4 days agoThe EMA Committee for Medicinal Products for Human Use is recommending approval of the drug for the treatment of adults with moderately to severely active ulcerative colitis ...
First results from late-breaking Phase 3 PALOMA-3 study show five-fold reduction in infusion-related...
Ram Page· 4 days agoJohnson & Johnson announced today first data from the Phase 3 PALOMA-3 study evaluating subcutaneous (SC) amivantamab combined with lazertinib in patients with locally advanced or metastatic ...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 1 day agoLate-breaking results from PALOMA-2 study of subcutaneous amivantamab in combination with lazertinib show clinically meaningful antitumor response and improved safety profile in patients with ...
AbbVie Receives Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with...
telegraphherald.com· 5 days agoThe positive opinion is based on results from two pivotal Phase 3 trials, INSPIRE and COMMAND, that evaluated the efficacy and safety of risankizumab in adults with moderately to severely
RYBREVANT® (amivantamab-vmjw) plus lazertinib is the only chemotherapy-free regimen showing longer...
Morningstar· 4 days agoInvestigational chemotherapy-free regimen of RYBREVANT® plus lazertinib addresses a significant unmet need as most patients with EGFR-mutated NSCLC have high-risk disease Landmark Phase 3 MARIPOSA ...
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following...
Digital Journal· 2 days ago“Bizaxofusp represents a promising novel approach for targeted delivery of a potent therapeutic payload in rGBM, a uniformly fatal form of brain cancer that does not have an approved standard ...
Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in...
Benzinga· 3 days agoSUZHOU, China, and ROCKVILLE, Md., June 1, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related
Landline 911 outage impacts parts of Iowa, including Scott, Muscatine, Clinton and Jackson counties
Quad-City Times· 5 days agoIowans can still call 911 using a cellphone, according to alerts from local county emergency...
Bitcoin Price Prediction: BTC Soars to $67,900; Mixed US Inflation Data & Fed Rate Cut Hopes Fuel...
Cryptonews· 4 days agoBitcoin surges to $67,900 as investors react to mixed US inflation data and growing anticipation of a potential Federal Reserve rate cut.